Company Details
| Sector | PHARMACEUTICALS |
| Address | 35 - Dockyard Road West Wharf Karachi |
| Auditor | Yousuf Adil, Chartered Accountants |
| Registrar | CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi |
| Website | www.pk.gsk.com |
| Fiscal Year | December |
| Details |
Details
GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V.@ incorporated in Netherlands@ whereas its ultimate parent company is GlaxoSmithKline plc@ UK (GSK plc).
Company Announcements
| Date/Time | Announcement |
|---|---|
| 28/08/2019 15:10:02 | FINANCIAL RESULT FOR THE HALF YEAR ENDED 30/06/2019 EPS = 2.75 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 874.588 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,586.813 |
| 24/04/2019 14:43:25 | FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 31/03/2019 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 817.623 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 532.910 EPS = 1.67 |
| 04/03/2019 16:53:04 | BOOK CLOSURE FROM 18/04/2019 FINANCIAL RESULT FOR THE YEAR ENDED 31/12/2018 DIVIDEND = 70%(F) PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 4,692.117 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 3,231.922 EPS = 10.23 ANNUAL GENERAL MEETING WILL BE HELD ON 24/04/2019 BOOK CLOSURE TO 24/04/2019 |
| 29/10/2018 17:55:54 | FINANCIAL RESULT FOR THE NINE MONTHS ENDED 30/09/2018 EPS = 5.87 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 1,871.375 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 3,211.480 |
| 13/08/2018 15:10:01 | EPS = 4.10 FINANCIAL RESULT FOR THE HALF YEAR ENDED 30/06/2018 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 1,304.285 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 2,222.945 |